Ocean Biomedical (OCEA) Stock Price, News & Analysis

Company Overview

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

Key Stats

• Today's Range: $0.46 to $0.72
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 9.12 million shs
• Average Volume: 43,195 shs
• Market Capitalization: $23.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OCEA Stock Analysis - Frequently Asked Questions

When did Ocean Biomedical IPO?

Ocean Biomedical (OCEA) raised $22 million in an IPO on the week of April 18th 2022. The company issued 2,000,000 shares at $10.00-$12.00 per share. Roth Capital Partners and JonesTrading acted as the underwriters for the IPO.

What other stocks do shareholders of Ocean Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ocean Biomedical investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Alphabet (GOOG), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:OCEA
• CUSIP: N/A
• CIK: 1836612
• Web: N/A
• Phone: 646-908-2658
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.62) per share
• Price / Book: -0.25

Miscellaneous

• Outstanding Shares: 34,820,000
• Free Float: 9,227,000
• Market Cap: $23.12 million
• Optionable: Optionable
• Beta: 1.38